Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
People with mitochondrial diseases should consult a specialist before using any compound that alters mitochondrial function
Our specialists will guide you through every step, explaining the benefits, how often to receive injections for the best outcome, and what each session entails
intravenous TB-4 Phase 1 safety and pharmacokinetics, no dose-limiting or serious adverse events (Ann N Y Acad Sci 2010;1194:223229): NCT00743769 On February 27, 2026, HHS Secretary Kennedy announced that GHK-Cu is among approximately 14 peptides expected to return to Category 1
Some patients have also experienced a hypersensitivity reaction following intramuscular injection that has resulted in anaphylactic shock and death
Proper storage protocols can prevent degradation, ensuring that the peptide remains effective for research, therapeutic, or other applications
US$ 27.49
US$ 27.86
US$ 20.60
US$ 27.09
